Benzimidazole derivatives which are to be used as anatgonist for the CB1-receptor

Details for Australian Patent Application No. 2007259425 (hide)

International Classifications

Event Publications

11 December 2008 PCT application entered the National Phase

PCT publication WO2007/145563 Priority application(s): WO2007/145563

29 January 2009 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the Name AstraZeneca AB, Application No. 2007259425, under INID (54) correct the title to read Benzimidazole derivatives which are to be used as antagonist for the CB1-receptor

8 September 2011 Application Accepted

Published as AU-B-2007259425

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.